Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways-Reference-Cited by-同舟云学术

Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways

Published:2019-04-16 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Zhou Mei,Sareddy Gangadhara R.,Li Mengxing,Liu Jinyou,Luo Yiliao,Venkata Prabhakar Pitta,Viswanadhapalli Suryavathi,Tekmal Rajeshwar R.,Brenner Andrew,Vadlamudi Ratna K.^ORCID

Funder

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-42313-8.pdf

Reference38 articles.

1. Ohgaki, H. & Kleihues, P. Genetic alterations and signaling pathways in the evolution of gliomas. Cancer Sci 100, 2235–2241, https://doi.org/10.1111/j.1349-7006.2009.01308.x (2009).

2. Omuro, A. & DeAngelis, L. M. Glioblastoma and other malignant gliomas: a clinical review. JAMA 310, 1842–1850, https://doi.org/10.1001/jama.2013.280319 (2013).

3. Tykocki, T. & Eltayeb, M. Ten-year survival in glioblastoma. A systematic review. J Clin Neurosci 54, 7–13, https://doi.org/10.1016/j.jocn.2018.05.002 (2018).

4. Cloughesy, T. F., Cavenee, W. K. & Mischel, P. S. Glioblastoma: from molecular pathology to targeted treatment. Annu Rev Pathol 9, 1–25, https://doi.org/10.1146/annurev-pathol-011110-130324 (2014).

5. Stupp, R. et al. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial. JAMA 318, 2306–2316, https://doi.org/10.1001/jama.2017.18718 (2017).

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gender differences in gliomas: From epidemiological trends to changes at the hormonal and molecular levels;Cancer Letters;2024-08

2. Unlocking estrogen receptor: Structural insights into agonists and antagonists for glioblastoma therapy;Advances in Protein Chemistry and Structural Biology;2024

3. O-GlcNAcylation of melanophilin enhances radiation resistance in glioblastoma via suppressing TRIM21 mediated ubiquitination;Oncogene;2023-11-10

4. Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma;Molecular Cancer Therapeutics;2023-07-25

5. Glioblastoma in pregnant patient with pathologic and exogenous sex hormone exposure and family history of high-grade glioma: A case report and review of the literature;Surgical Neurology International;2023-05-12